Clinical Report: Epidemiological Analysis of Dementia With Lewy Bodies

Overview

This comprehensive review and meta-analysis aims to quantify the global incidence and prevalence of dementia with Lewy bodies (DLB) by pooling data from population-based studies.

Background

Dementia with Lewy bodies is a major neurodegenerative disorder and the second most common cause of dementia after Alzheimer's disease. It presents diagnostic challenges due to its overlap with other neurodegenerative diseases and is associated with higher mortality and caregiver burden compared to Alzheimer's disease.

Data Highlights

No numerical data was provided in the source material.

Key Findings

• DLB is characterized by abnormal aggregation of α-synuclein into Lewy bodies and neurites.
• It presents with cognitive decline, visual hallucinations, REM sleep behavior disorder, and parkinsonism.
• DLB has a higher mortality rate and greater health care utilization compared to Alzheimer's disease.
• The review aims to address the gap in knowledge regarding DLB epidemiology by pooling data from various studies.

Clinical Implications

The findings from this meta-analysis can inform health care planning and policy for individuals with DLB. Understanding the epidemiological data can aid in resource allocation and improve care strategies for patients and caregivers.

Conclusion

This systematic review and meta-analysis provides critical insights into the global burden of DLB, highlighting the need for standardized data collection methods in future studies.

Related Resources & Content

1. JAMA Neurology, 2026 -- Incidence and Prevalence of Dementia With Lewy Bodies: A Systematic Review and Meta-Analysis
2. PMC, 2024 -- Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
3. Brain, 2023 -- Unique transcriptional changes differentiate Lewy body dementia from Alzheimer’s disease
4. Acta Neuropathologica, 2026 -- Spatially resolved molecular signatures of Lewy body dementia
5. Acta Neuropathologica, 2026 -- Correlative ultrastructural mapping of Lewy pathology reveals regional diversity in Parkinson’s and dementia with Lewy bodies
6. Brain — The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients
7. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium - PMC
8. Incidence and Prevalence of Dementia With Lewy Bodies: A Systematic Review and Meta-Analysis | Neurology | JAMA Neurology | JAMA Network
9. Efficacy and Safety of Donepezil for Lewy Body Dementia: A Systematic Review and Meta‐Analysis - PMC